Published 4 November 2009, doi:10.1136/bmj.b4316
Cite this as: BMJ 2009;339:b4316

Endgames

Picture Quiz

An occult breast mass

C J Burke, specialist registrar radiology, R Thomas, specialist registrar radiology, D C Howlett, consultant radiologist

1 Department of Radiology, Eastbourne General Hospital, Eastbourne, East Sussex BN21 2UD

Correspondence to: C J Burke, 42 Arminger Road, London W12 7BB drchristopherburke{at}gmail.com

A 69 year old woman was referred by her general practitioner to the rapid access breast clinic because of a two week history of painless swelling in the upper left breast. She had no history of nipple change or discharge, and she was otherwise well with no medical history of note. On clinical examination she had a firm, ill defined, and non-tender swelling above the left nipple, with no palpable axillary nodes. Free hand, fine needle aspiration was undertaken and she was referred for imaging. Bilateral mammography showed moderately dense breast tissue only, and no focal lesion was seen on ultrasound of the left breast.

Results of needle cytology showed benign cells only. Because of persisting clinical concern and the dense breast tissue seen on mammography, breast magnetic resonance imaging was performed. Figure 1Go is an axial post-contrast, fat saturated magnetic resonance image through the superior portion of the breasts. This is a sequence that removes the signal from normal breast tissue, thereby highlighting areas of enhancement only.


Figure 1
View larger version (139K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
 
Fig 1 An axial post-contrast, fat saturated magnetic resonance image through the superior portion of the breasts

 

Questions

1 What radiological abnormalities are present?
2 What is the likely diagnosis?
3 What are the indications for breast magnetic resonance imaging in everyday practice?
4 How should this patient be managed?

Answers

Short answers

1 The left breast has a large ill defined, lobulated, and enhancing lesion in the centre, with surrounding satellite nodules. The right breast has a smaller, medially located, ill defined enhancing nodule. Both masses have associated pathological circulation, which is more marked on the left.
2 The lesions are consistent with bilateral breast carcinoma, which is multifocal on the left. They are probably malignant—they enhance avidly, are irregular with ill defined margins, have pathological circulation, and satellite lesions are seen on the left.
3 In younger symptomatic patients with prominent glandular tissue and dense mammograms where lesions can be obscured, magnetic resonance imaging often provides reassurance that no lesion is present. It is the best method for assessing breast implants for suspected leakage and looking for tumour recurrence after breast surgery.1 2 3 4 5 6 It is also useful for evaluating multifocal or lobular carcinoma or suspected chest wall invasion,1 2 3 4 5 6 and it has been proposed as a primary screening tool in young high risk BCRA positive patients.7 8 9 10 11
4 Firstly, establish a histological diagnosis. Focused ultrasound of the medial right breast identified a 12 mm lesion, so ultrasound guided core biopsy was carried out. Sample biopsies of the central left breast at the level of the abnormality confirmed invasive lobular carcinoma bilaterally. Clinical examination, needle biopsy, and imaging all play complementary roles in such cases. The management of lobular carcinoma is complex and may include surgery, hormone therapy (depending on oestrogen receptor status), chemotherapy, and radiotherapy.

Long answers
1 Radiological abnormalities
The magnetic resonance image showed a large ill defined, lobulated, and enhancing lesion located centrally within the left breast surrounded by satellite nodulesGo. A smaller ill defined enhancing nodule was also seen medially within the right breast. Both these masses showed pathological circulation, which was more marked on the left.


Figure 2
View larger version (140K):
[in this window]
[in a new window]
[PowerPoint Slide for Teaching]
 
Fig 2 An axial post-contrast, fat saturated magnetic resonance image through the superior portion of the breasts. A large ill defined, lobulated, and enhancing lesion (A) is seen centrally within the left breast with surrounding satellite nodules. A smaller ill defined enhancing nodule is also noted medially within the right breast (B). These masses both show pathological circulation, which is more marked on the left (C)

 
2 Likely diagnosis
These findings are consistent with bilateral breast carcinoma, which is multifocal on the left. These lesions are likely to be malignant because they are spiculated, enhance avidly, and are irregular with ill defined margins. The associated pathological circulation and the satellite lesions on the left are also in keeping with invasive malignancy.1 Further features of malignancy on magnetic resonance imaging are rapid enhancement and washout characteristics.

3 Indications for breast magnetic resonance imaging in everyday practice
Magnetic resonance imaging of the breast is being increasingly used in everyday practice as a problem solving tool with a widening spectrum of potential applications. It is often helpful in patients who present with a palpable abnormality, but where initial breast imaging is negative or inconclusive (as in our case).

In patients with prominent glandular tissue and dense mammograms, particularly younger women, where lesions can be obscured, magnetic resonance imaging can be especially helpful in reassuring both patient and clinician that no lesion is present. It is the technique of choice when assessing breast implants for suspected leakage and looking for suspected tumour recurrence after breast surgery.1 2 3 4 5 6 Other indications for breast magnetic resonance imaging include evaluation of multifocal or lobular carcinoma or where chest wall invasion is suspected.1 2 3 4 5 6 Magnetic resonance imaging has also been proposed as a primary screening tool in young high risk BCRA positive patients.7 8 9 10 11

Although magnetic resonance imaging is a useful problem solving tool in breast imaging, it does have disadvantages and contraindications. A dedicated breast coil, which can be uncomfortable, is required. The scan can last up to 30 minutes and patients may feel claustrophobic, which results in a high failure rate. The technique is increasingly available in most breast units but is expensive compared with other breast imaging modalities. Magnetic resonance imaging can also pick up incidental abnormalities and lead to unnecessary additional surgery, investigation, and stress for the patient.3 4 5 6

4 Further management
The immediate further management is to establish a histological diagnosis. This was achieved by focused ultrasound of the medial right breast, which identified a 12 mm lesion. Ultrasound guided core biopsy under local anaesthesia was then performed. Sample biopsies were also taken from the central area of the left breast using ultrasound, and these biopsies confirmed invasive lobular carcinoma bilaterally. Alternatively, surgical excision biopsy or magnetic resonance imaging guided biopsy (although not widely available) could have been used to obtain samples.

Infiltrating lobular carcinoma makes up 5-10% of all invasive breast carcinomas.1 The median age at presentation is 45-56 years, with 2% of cases occurring in women under 35.1 2 It is the second most common form of the disease after ductal carcinoma. Thirty per cent to 50% of patients develop a second primary in the same or contralateral breast within 20 years.1 It is the most commonly missed breast cancer overall—it is difficult to detect mammographically and clinically, and it has a 19-43% false negative rate radiologically (occult in dense breast tissue).1 2 Because of the tendency for multifocality and bilaterality, once lobar carcinoma has been identified, magnetic resonance imaging is increasingly being used to screen the remaining breast for lesions.

Disease is multicentric in 30% of patients and bilateral in 10%. The tumour tends to grow around ducts, vessels, and lobules without destruction of anatomical structures (targetoid growth). There is also a propensity for desmoplastic stromal reaction. Prognosis is poor, often because of the late diagnosis.1 2

Lobular carcinoma is managed by surgery, hormone therapy (depending on oestrogen receptor status), chemotherapy, and radiotherapy.

Patient outcome

The patient underwent bilateral mastectomy with axillary node clearance. She was referred for chemotherapy, and because the tumour was oestrogen receptor positive, she will also receive hormone therapy.

Cite this as: BMJ 2009;339:b4316


Competing interests: None declared.

Provenance and peer review: Not commissioned; not externally peer reviewed.

Patient consent obtained.

References

  1. Dahnert W. Radiology review manual. 6th ed. Lipincott Williams and Wilkins, 2007.
  2. Lopez JK, Bassett LW. Invasive lobular carcinoma of the breast: spectrum of mammographic, US, and MR imaging findings. Radiographics 2009;29:165-76.[Abstract/Free Full Text]
  3. Lee CH. Problem solving MR imaging of the breast. Radiol Clin North Am 2004;42:919-34.[CrossRef][Web of Science][Medline]
  4. Mann RM, Kuhl CK, Kinkel K, Boetes C. Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 2008;18:1307-18.[CrossRef][Web of Science][Medline]
  5. Pediconi F, Catalano C, Roselli A, Padula S, Altomari F, Moriconi E, et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007;243:670-80.[Abstract/Free Full Text]
  6. Vandermeer FQ, Bluemke DA. Breast MRI: state of the art. Cancer Invest 2007;25:384-92.[CrossRef][Web of Science][Medline]
  7. Lalonde L, David J, Trop I. Magnetic resonance imaging of the breast: current indications. Can Assoc Radiol J 2005;56:301-8.[Web of Science][Medline]
  8. Lee JM, Kopans DB, McMahon PM, Halpern EF, Ryan PD, Weinstein MC, et al. Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging—Markov Monte Carlo decision analysis. Radiology 2008;246:763-71.[Abstract/Free Full Text]
  9. Warner E, Plewes DB, Hill KA, Causer PA, Zubovits JT, Jong RA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-25.[Abstract/Free Full Text]
  10. Lord SJ, Lei W, Craft P, Cawson JN, Morris I, Walleser S, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 2007;43:1905-17.[CrossRef][Web of Science][Medline]
  11. Elmore JG, Armstrong K, Lehman CD, Fletcher SW. Screening for breast cancer. JAMA 2005;293:1245-56.[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?



Access jobs at BMJ Careers
Whats new online at Student 

BMJ